Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Using a quick CT scan to check for left atrial clots before cardioversion in the Emergency Department

Official title: Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)

Run by Ottawa Heart Institute Research Corporation · NCT07002450 · Data updated 2026-11-12

This will test whether a rapid cardiac CT in the ED to look for left atrial clots lets people with symptomatic atrial fibrillation or flutter have safe same‑day cardioversion instead of being admitted or delayed.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment190 (estimated)
SponsorOttawa Heart Institute Research Corporation
Academic / other
Drugs / interventionsradiation
Locations3 sites (Hershey, Pennsylvania and 2 other locations)
StatusRecruiting
StartedJune 15, 2025
Main results expectedJune 15, 2028
Study endsJune 15, 2028
Registry record updatedJune 9, 2026
Trial IDNCT07002450 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with symptomatic atrial fibrillation or atrial flutter who require left atrial imaging before cardioversion and who are hemodynamically stable and able to receive iodinated contrast and hold their breath for the scan are ideal candidates.

Probably not a fit

Patients who need emergency cardioversion for instability or who cannot undergo CCT (severe renal impairment, contrast allergy, pregnancy, or inability to breath‑hold) are unlikely to benefit from this CT‑facilitated approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized multicenter trial compares cardiac computed tomography angiography (CCT)–facilitated cardioversion in the emergency department to current standard care for patients with symptomatic atrial fibrillation or flutter who need left atrial imaging before cardioversion. Patients randomized to the CCT arm will have a CT to rule out thrombus and, if no clot is seen, may undergo immediate chemical or electrical cardioversion in the ED; the control arm follows local standard practice (which may include TEE, admission, or outpatient anticoagulation). The study will measure hospital admission rates, repeat ED presentations, and patient quality of life with follow-up at 30 days. CCT is more widely available than TEE and has shown high sensitivity and specificity for detecting left atrial thrombus in diagnostic studies, so this trial tests the pathway impact of using CCT in real-world ED care.

Why it matters

Potential benefit: If successful, eligible patients could be cardioverted safely in the ED after a rapid CT, reducing hospital admissions, repeat visits, and time spent in symptomatic arrhythmia.

How similar studies have gone: Diagnostic studies show CCT has high sensitivity and specificity compared with TEE for detecting atrial thrombus, but randomized trials of ED CCT‑guided cardioversion are limited, making this approach relatively novel in trial form.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years old; and
2. Primary symptomatic AF without a reversible underlying cause (e.g. sepsis, pneumonia, pulmonary embolism, hyperthyroidism)
3. LA imaging required before cardioversion according to local clinical practice guidelines

Exclusion Criteria:

1. Patients with an indication for emergency cardioversion (e.g. hemodynamic instability (systolic blood pressure\<90mmHg or signs of shock), cardiac ischemia (ongoing severe chest pain or marked ST depression on ECG \>2mm), or pulmonary edema (significant dyspnea, crackles, or hypoxia)); or
2. Contraindication to CCT (renal insufficiency (eGFR\< 45ml/min/1.73m2), allergy to intravenous contrast agents, pregnancy (contraindications to radiation exposure), or inability to perform 20-second breath-hold)

Where it's running

  • Penn State Health Milton S. Hershey Medical Center
    Hershey, Pennsylvania, United States
    Recruiting
  • The Ottawa Hospital Civic Campus
    Ottawa, Ontario, Canada
    Recruiting
  • Sunnybrook Health Sciences Centre
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Benjamin Chow, MD PhD FRCPC FACC FESC FA — Ottawa Heart Institute Research Corporation
  • Study coordinator: Farrah Ahmed
  • Email: fahmed@ottawaheart.ca
  • Phone: 613-696-7000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.